SI
Sofinnova Investments’s NextCure NXTC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.23M | Hold |
2,671,856
| – | – | 0.08% | 45 |
|
2025
Q1 | $1.28M | Hold |
2,671,856
| – | – | 0.08% | 51 |
|
2024
Q4 | $2.06M | Hold |
2,671,856
| – | – | 0.15% | 47 |
|
2024
Q3 | $3.66M | Hold |
2,671,856
| – | – | 0.29% | 44 |
|
2024
Q2 | $4.25M | Hold |
2,671,856
| – | – | 0.22% | 51 |
|
2024
Q1 | $5.96M | Hold |
2,671,856
| – | – | 0.33% | 45 |
|
2023
Q4 | $3.05M | Hold |
2,671,856
| – | – | 0.17% | 43 |
|
2023
Q3 | $3.45M | Hold |
2,671,856
| – | – | 0.22% | 39 |
|
2023
Q2 | $4.81M | Hold |
2,671,856
| – | – | 0.32% | 37 |
|
2023
Q1 | $3.95M | Hold |
2,671,856
| – | – | 0.25% | 40 |
|
2022
Q4 | $3.77M | Hold |
2,671,856
| – | – | 0.22% | 38 |
|
2022
Q3 | $7.35M | Hold |
2,671,856
| – | – | 0.43% | 33 |
|
2022
Q2 | $12.6M | Hold |
2,671,856
| – | – | 1.05% | 23 |
|
2022
Q1 | $13M | Hold |
2,671,856
| – | – | 0.99% | 22 |
|
2021
Q4 | $16M | Hold |
2,671,856
| – | – | 0.94% | 26 |
|
2021
Q3 | $18M | Hold |
2,671,856
| – | – | 1.07% | 17 |
|
2021
Q2 | $21.5M | Hold |
2,671,856
| – | – | 1.24% | 20 |
|
2021
Q1 | $26.7M | Buy |
+2,671,856
| New | +$26.7M | 1.61% | 15 |
|
2020
Q4 | – | Sell |
-2,671,856
| Closed | -$23.5M | – | 71 |
|
2020
Q3 | $23.5M | Hold |
2,671,856
| – | – | 1.74% | 13 |
|
2020
Q2 | $57.3M | Hold |
2,671,856
| – | – | 3.61% | 6 |
|
2020
Q1 | $99M | Hold |
2,671,856
| – | – | 9.16% | 3 |
|
2019
Q4 | $151M | Buy |
2,671,856
+150,000
| +6% | +$8.45M | 10.85% | 2 |
|
2019
Q3 | $77.8M | Hold |
2,521,856
| – | – | 7.03% | 4 |
|
2019
Q2 | $37.8M | Buy |
+2,521,856
| New | +$37.8M | 3.47% | 9 |
|